-
Chaodong Wu - Professor and Faculty Fellow
- Office:
- 217A Cater-Mattil
- Email:
- cdwu@tamu.edu
- Phone:
- 979-458-1521
- http://nfscfaculty.tamu.edu/wu
- Undergraduate Education
- Hubei University of Chinese Medicine (Wuhan), China. MD, Medicine, 1992
- Graduate Education
- Tongji Medical University (Wuhan), China. Master of Medical Science, 1995
- Beijing Medical University, China. PhD in Medical Science, 1998
- Awards
- Junior Faculty Award, American Diabetes Association, 2010
- Research Award, Minnesota Medical Foundation, 2004
- Travel Award, Dept. of BMBB, the University of Minnesota, 2001
- Pilot & Feasibility Research Award, Minnesota Obesity Center, 2002, 2005
- Travel Award, The Center for Diabetes Research, University of Minnesota, 2001
- Courses Taught
- NUTR 470: Nutrition and Physiological Chemistry
- NUTR 681: Nutrition Seminar
Research Interest
The long-term goal of Dr. Wu’s research program is to elucidate the mechanisms underlying the pathogenesis of obesity and overnutrition-associated metabolic diseases including insulin resistance, diabetes, and fatty liver disease so that novel dietary and/or pharmacological approaches can be developed for preventing and/or treating metabolic diseases. Using molecular, cellular, and integrative approaches, the Wu lab is focused on investigating the interaction between metabolism and inflammation.
Research Area
Obesity, insulin resistance, diabetes, and fatty liver disease
Publications
- Li, H, Zheng, J, Xu, Q, Yang, Y, Zhou, J, Guo, X et al.. Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation. Gastroenterology. 2022; :. doi: 10.1053/j.gastro.2022.09.027. PubMed PMID:36181835 .
- He, L, Wang, X, Ding, Z, Liu, L, Cheng, H, Bily, D et al.. Deleting Gata4 in hepatocytes promoted the progression of NAFLD via increasing steatosis and apoptosis, and desensitizing insulin signaling. J Nutr Biochem. 2023;111 :109157. doi: 10.1016/j.jnutbio.2022.109157. PubMed PMID:36150682 .
- Cheng, Q, Wu, C, Guo, L, Hu, J. Editorial: The relationship between sarcopenia and metabolic diseases: Its formation mechanism and intervention means. Front Endocrinol (Lausanne). 2022;13 :972238. doi: 10.3389/fendo.2022.972238. PubMed PMID:36093114 PubMed Central PMC9453858.